ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

A New Treatment for Breast Cancer Patients with Brain Metastases: An Interview with Dr. Nancy Lin

Автор: Breast Cancer Research Foundation

Загружено: 2020-07-16

Просмотров: 1818

Описание: As many as half of patients diagnosed with metastatic HER2-positive breast cancer will see their cancer spread to their brain. Though brain metastases, or "brain mets," are rare, they are exceedingly difficult to treat, so these patients experience poor outcomes.

At this year’s ASCO meeting, Dr. Nancy Lin of Dana-Farber Cancer Institute, presented promising results from the HER2CLIMB trial for these patients.

In this video BCRF talks with Dr. Lin about her research focus, brain mets, and HER2CLIMB’s findings.

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
A New Treatment for Breast Cancer Patients with Brain Metastases: An Interview with Dr. Nancy Lin

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

Optimizing Treatment for the Best Possible Outcomes: An Interview with Dr. Lisa Carey

Optimizing Treatment for the Best Possible Outcomes: An Interview with Dr. Lisa Carey

How to select treatment for HER2+ breast cancer patients with brain metastasis?

How to select treatment for HER2+ breast cancer patients with brain metastasis?

*Удивительно* Что я узнала, прекратив приём ТАМОКСИФЕНА | Гормональная терапия | История борьбы с...

*Удивительно* Что я узнала, прекратив приём ТАМОКСИФЕНА | Гормональная терапия | История борьбы с...

HER2-Positive Breast Cancer—Reduce Your Risk of Recurrence | Access Health

HER2-Positive Breast Cancer—Reduce Your Risk of Recurrence | Access Health

Behind The Breakthroughs: National Mammography Day 2023

Behind The Breakthroughs: National Mammography Day 2023

Unraveling Metastatic Breast Cancer: The Latest Treatments in Improving Outcomes

Unraveling Metastatic Breast Cancer: The Latest Treatments in Improving Outcomes

Treating brain mets

Treating brain mets

Behind the Breakthroughs: Global Breast Cancer Disparities

Behind the Breakthroughs: Global Breast Cancer Disparities

Fundraisers in Action: Fueling Progress Together

Fundraisers in Action: Fueling Progress Together

Robin Roberts on Surviving Cancer

Robin Roberts on Surviving Cancer

The Risk Revolution: AI's role in breast cancer risk, prevention and diagnosis

The Risk Revolution: AI's role in breast cancer risk, prevention and diagnosis

Exploring Breakthrough Treatments in Metastatic Breast Cancer

Exploring Breakthrough Treatments in Metastatic Breast Cancer

Research Update for HER2-Positive MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

Research Update for HER2-Positive MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

8 лет с диагнозом саркома. История из жизни Юлии Черной

8 лет с диагнозом саркома. История из жизни Юлии Черной

Donald Tusk: Konferencja prasowa, Paryż, 06.01.2026

Donald Tusk: Konferencja prasowa, Paryż, 06.01.2026

Brain Metastases in HER2-Positive Breast Cancer

Brain Metastases in HER2-Positive Breast Cancer

Brain Metastases: Symptoms, Diagnosis, Treatment | Mass General Brigham

Brain Metastases: Symptoms, Diagnosis, Treatment | Mass General Brigham

2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment Approaches

2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment Approaches

Medical Update: HER2-Positive Metastatic Breast Cancer

Medical Update: HER2-Positive Metastatic Breast Cancer

HER2+ Breast Cancer: Brain Metastasis Prevalence & Later-Line Therapy

HER2+ Breast Cancer: Brain Metastasis Prevalence & Later-Line Therapy

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]